Silvercrest Asset Management Group LLC Dexcom Inc Transaction History

Silvercrest Asset Management Group LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $582,970 - $934,337	-6,774 Reduced 18.14%	30,576 $2.85 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $552,790 - $643,766	4,915 Added 15.15%	37,350 $4.8 Million
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $593,736 - $701,750	5,709 Added 21.36%	32,435 $3.77 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $247,886 - $357,828	2,917 Added 12.25%	26,726 $3.03 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $249,817 - $308,156	3,272 Added 15.93%	23,809 $1.92 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $1.24 Million - $2.42 Million	18,237 Added 792.91%	20,537 $1.53 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $1,038 - $1,302	-8 Reduced 0.35%	2,300 $1.24 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $246,286 - $330,459	2,308 New	2,308 $1.26 Million
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $44,396 - $70,260	-929 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$36.62 - $57.29 $17,101 - $26,754	-467 Reduced 33.45%	929 $203,000
Q3 2019 Nov 14, 2019	BUY	$35.53 - $43.8 $49,599 - $61,144	1,396 New	1,396 $208,000

1,084

352M

8.45M

5.75M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33.2B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.